Research Design (-14)This workshop will provide participants with:
1. An overview of pre-clinical device evaluation
requirements (laboratory and animal studies) for IDE
submission.
2. A discussion of IRB regulations for human subject
research and guidelines for submitting IRB protocols.
3. An overview of good clinical investigations includ
ing study design (pilot studies, variables, controls,
sample size, blinding and bias), study conduct, and
analysis.
R. Shlansky-Goldberg, MD
P. Cole, MD, PhD
Manager, Office of Device Evaluation, FDA (TEA)
Room Design and Equipment Purchase (-15)Workshop attendants will learn:
1. How to evaluate and complete various angiographic
systems.
2. How to evaluate the need for optional features in
angiographic systems.
3. What to consider in the design of an angiography
suite.
D. Trost, MD-
Searching for aJob (-16)Participants attending this workshop will gain an under
standing of:
1. The differences between private and academic
practices and how these impact on an interventional
practice.
2. An outline of the important steps in the job search
and interview process.
3. The strategies to employ in defining a job descrip
tion for an interventional radiologist.
J. Van Hove, MD*
F. Taylor, MD
368
Workshops
Spiral CT (-17)The objectives of this workshop are:
1. To provide a background on the utility and role of
spiral CT angiography from an interventionalist's
perspective. Do I need it? How do I get full use out
of its capabilities?
2. To discuss and review the merits and weaknesses of
spiral CT relative to conventional angiography. What
can it do, what can't it do?
3. To provide a forum for determining whether acquisi
tion of a spiral scanner will have benefit for your
practice - from routine tomographic scanning to
planning complex interventional procedures. Why
should my practice spend over a half-million dollars
for the scanner? Is it worth it?
C. Semba, MD'
S. Kee, MD
Introductory Thrombolysis (-18;)
Thrombolysis (-18)At the conclusion of the workshop session, the partici
pant will:
1. Understand the key biochemical pathways in throm
bolysis and the pharmacology of thrombolytic agents.
2. Know the clinical indications and contraindications
for thrombolytic therapy in the arterial and venous
systems.
3. Be familiar with the various delivery systems and
dosage regimens used in thrombolysis.
4. Be able to evaluate the initial and long-term results
of thrombolytic therapy.
5. Appreciate patient management issues including
potential complications.
Faculty -Introductory and Advanced 1bromboZysis
D. Zuckerman, MD' M. Meyerovitz, MD
J. Benenati, MD K. Openshaw, MD
J. Cynamon, MD A. Roberts, MD
T. Egglin, MD D. Siegel, MD
C. Jarmolowski, MD K. SUllivan, MD
S. Kaufman, MD D. Trost, MD
T. McNamara, MD
Recommended
